Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Ixabepilone and SBRT For Metastatic Breast Cancer

This study has been terminated.
(low accrual)
Sponsor:
Information provided by (Responsible Party):
University of Texas Southwestern Medical Center
ClinicalTrials.gov Identifier:
NCT01818999
First received: March 6, 2013
Last updated: October 23, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2023
  Estimated Primary Completion Date: December 2016 (Final data collection date for primary outcome measure)